Peijia Medical (HKSE:09996) Net Income From Continuing Operations : HK$-429.4 Mil (TTM As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Peijia Medical Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Peijia Medical's net income from continuing operations for the six months ended in Jun. 2023 was HK$-232.0 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-429.4 Mil.

Peijia Medical Net Income From Continuing Operations Historical Data

The historical data trend for Peijia Medical's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peijia Medical Net Income From Continuing Operations Chart

Peijia Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

-591.96

-2,452.25

-703.11

-444.72

-429.37

Peijia Medical Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Income From Continuing Operations	Get a 7-Day Free Trial						-488.61	-107.83	-352.68	-231.96	-197.40

Peijia Medical Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-429.4 Mil.

Peijia Medical (HKSE:09996) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Peijia Medical Ltd (HKSE:09996) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Zhongtian Street, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN

Website

https://www.peijiamedical.com

Peijia Medical Ltd is focused on the interventional procedural, transcatheter valve therapeutic, and the neurointerventional procedural medical device market in China. The company's product candidates include Transcatheter Aortic Valve Replacement products, Transcatheter Mitral Valve Replacement/Transcatheter Tricuspid Valve Replacement products, Ancillary products, Neurointerventional products, and its product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates. Its operating segments are Transcatheter Valve Therapeutic Business and Neurointerventional Business.

Executives

Jinnius Drive Trust	2103 Interests held jointly with another person
Xinyue International Limited	2103 Interests held jointly with another person
Ye Hong	2103 Interests held jointly with another person
Zhang Ping Ye	2103 Interests held jointly with another person
Zhang Yi	2301 Trustee
Hanlindale Trust	2103 Interests held jointly with another person
Hillhouse Investment Management, Ltd.	2102 Investment manager
Hh Imv Holdings, L.p.	2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Hh Sum-xxiv Holdings Limited	2101 Beneficial owner
Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Lav Asset Management (hong Kong) Limited	2102 Investment manager
Shi Yi	2201 Interest of corporation controlled by you

Peijia Medical (HKSE:09996) Headlines

No Headlines